Originally published byEU-Startups
British BioTech startup Houdini Bio has exited out of stealth today with approximately €1.7 million (£1.5 million) in pre-Seed funding in order to validate its DNA sequence design infrastructure platform – engineered to overcome the biological barriers limiting genetic medicines. The round was led by SCVC (the venture arm of Science Creates), with participation from Deep […]
The post Houdini Bio emerges from stealth with €1.7 million to tackle DNA silencing in gene therapies appeared first on EU-Startups.
🌐
More news from European UnionEuropean Union
EUROPE
Related News
EU won't force publishers to grant dead video games an afterlife
1d ago
Tensordyne makes a big bet on log math to beat Nvidia
1d ago
‘None of us will do it alone’: European solidarity takes over VivaTech
1d ago
Why Amazon hates 'human-in-the-loop' AI governance
21h ago
Britain sending Ukraine an extra 30,000 drones – now 150,000 all up
1d ago